News

2023.03.22
Webinar with the Management Board of Genomtec

2023.03.21
Genomtec wants the Shareholders to participate in the benefits of the potential M&A transaction to the largest possible extent

2023.03.07
Puls Biznesu: Genomtec wants to strengthen with a share issue

2023.02.28
Genomtec S.A. intensifies M&A process

2023.02.16
Genomtec S.A. debuted on the Main Market of the Warsaw Stock Exchange

Archive

2023.03.22

Webinar with the Management Board of Genomtec

A webinar with Genomtec Management Board organized by the Warsaw Stock Exchange will be held on Friday, March 24, at 4:00 pm. Link to the ...
Read
2023.03.21

Genomtec wants the Shareholders to participate in the benefits of the potential M&A transaction to the largest possible extent

According to the adopted resolution, the Issuer’s Management Board will take all reasonable steps to ensure the Shareholders’ ...
Read
2023.03.07

Puls Biznesu: Genomtec wants to strengthen with a share issue

In February, the company announced plans for a share issue of up to 1.64 million shares, which will represent 14 percent of the company’s ...
Read
2023.02.28

Genomtec S.A. intensifies M&A process

The management board of Genomtec S.A., a medical technology company, plans to raise additional funds to support maximization of the ...
Read
2023.02.16

Genomtec S.A. debuted on the Main Market of the Warsaw Stock Exchange

On 16th February 2023, Genomtec S.A. debuted on the Main Market of the Warsaw Stock Exchange Video from the debut: ...
Read
2023.02.09

Genomtec’s first listing on the Main Market of the Warsaw Stock Exchange

16 February 2023 – the date for Genomtec’s first listing on the Main Market of the Warsaw Stock Exchange. We have great pleasure to invite all ...
Read

Archive